Fernando Caravaggio
Fernando Caravaggio
University of Toronto. Centre for Addiction & Mental Health.
Verified email at
Cited by
Cited by
Kynurenic acid in schizophrenia: a systematic review and meta-analysis
E Plitman, Y Iwata, F Caravaggio, S Nakajima, JK Chung, P Gerretsen, ...
Schizophrenia bulletin 43 (4), 764-777, 2017
The potential role of dopamine D3 receptor neurotransmission in cognition
S Nakajima, P Gerretsen, H Takeuchi, F Caravaggio, T Chow, B Le Foll, ...
European Neuropsychopharmacology 23 (8), 799-813, 2013
Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia
NE MacKenzie, C Kowalchuk, SM Agarwal, KA Costa-Dookhan, ...
Frontiers in psychiatry 9, 622, 2018
Glutamate-mediated excitotoxicity in schizophrenia: a review
E Plitman, S Nakajima, C de la Fuente-Sandoval, P Gerretsen, ...
European Neuropsychopharmacology 24 (10), 1591-1605, 2014
Individual determinants of COVID-19 vaccine hesitancy
P Gerretsen, J Kim, F Caravaggio, L Quilty, M Sanches, S Wells, ...
PloS one 16 (11), e0258462, 2021
Glutamatergic neurometabolite levels in patients with ultra-treatment-resistant schizophrenia: a cross-sectional 3T proton magnetic resonance spectroscopy study
Y Iwata, S Nakajima, E Plitman, F Caravaggio, J Kim, P Shah, W Mar, ...
Biological psychiatry 85 (7), 596-605, 2019
Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials
Y Iwata, S Nakajima, T Suzuki, RSE Keefe, E Plitman, JK Chung, ...
Molecular psychiatry 20 (10), 1151-1160, 2015
Neuroimaging findings in treatment-resistant schizophrenia: a systematic review: lack of neuroimaging correlates of treatment-resistant schizophrenia
S Nakajima, H Takeuchi, E Plitman, G Fervaha, P Gerretsen, ...
Schizophrenia research 164 (1-3), 164-175, 2015
Insight and medication adherence in schizophrenia: An analysis of the CATIE trial
J Kim, M Ozzoude, S Nakajima, P Shah, F Caravaggio, Y Iwata, ...
Neuropharmacology 168, 107634, 2020
Evaluation of antipsychotic dose reduction in late-life schizophrenia: a prospective dopamine D2/3 receptor occupancy study
A Graff-Guerrero, TK Rajji, BH Mulsant, S Nakajima, F Caravaggio, ...
JAMA psychiatry 72 (9), 927-934, 2015
The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: a systematic review
P Shah, Y Iwata, E Plitman, EE Brown, F Caravaggio, J Kim, S Nakajima, ...
Psychiatry research 268, 114-122, 2018
Reduced Insulin Sensitivity Is Related to Less Endogenous Dopamine at D2/3 Receptors in the Ventral Striatum of Healthy Nonobese Humans
F Caravaggio, C Borlido, M Hahn, Z Feng, G Fervaha, P Gerretsen, ...
International Journal of Neuropsychopharmacology 18 (7), pyv014, 2015
Ventral striatum binding of a dopamine D2/3 receptor agonist but not antagonist predicts normal body mass index
F Caravaggio, S Raitsin, P Gerretsen, S Nakajima, A Wilson, ...
Biological psychiatry 77 (2), 196-202, 2015
Lifetime history of depression predicts increased amyloid- accumulation in patients with mild cognitive impairment
JK Chung, E Plitman, S Nakajima, TW Chow, MM Chakravarty, ...
Journal of Alzheimer's Disease 45 (3), 907-919, 2015
Neurometabolite levels in antipsychotic-naïve/free patients with schizophrenia: A systematic review and meta-analysis of 1H-MRS studies
Y Iwata, S Nakajima, E Plitman, Y Mihashi, F Caravaggio, JK Chung, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 86, 340-352, 2018
The VAGUS insight into psychosis scale–self-report and clinician-rated versions
P Gerretsen, G Remington, C Borlido, L Quilty, S Hassan, G Polsinelli, ...
Psychiatry research 220 (3), 1084-1089, 2014
Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment
M Wada, Y Noda, Y Iwata, S Tsugawa, K Yoshida, H Tani, Y Hirano, ...
Molecular Psychiatry 27 (7), 2950-2967, 2022
A meta-analysis of transcranial direct current stimulation for schizophrenia:“Is more better?”
J Kim, Y Iwata, E Plitman, F Caravaggio, JK Chung, P Shah, ...
Journal of psychiatric research 110, 117-126, 2019
Cortical amyloid deposition and current depressive symptoms in Alzheimer disease and mild cognitive impairment
JK Chung, E Plitman, S Nakajima, MM Chakravarty, F Caravaggio, ...
Journal of geriatric psychiatry and neurology 29 (3), 149-159, 2016
Depressive symptoms and small hippocampal volume accelerate the progression to dementia from mild cognitive impairment
JK Chung, E Plitman, S Nakajima, MM Chakravarty, F Caravaggio, ...
Journal of Alzheimer's Disease 49 (3), 743-754, 2016
The system can't perform the operation now. Try again later.
Articles 1–20